Skip to main content

Psychiatry, Mental Health and Addictions

The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:

  • Neurodevelopmental Disorders (especially Attention-Deficit / Hyperactivity Disorder, Autism and Fetal Alcohol Syndrome).
  • Personality Disorders (especially Borderline Personality Disorder).
  • Addictive behaviours (especially Dual Pathology and Smoking).
  • Transcultural Psychiatry.
  • Interconsultation and Liaison Psychiatry.
  • Resistant Major Depressive Disorder.
  • Perinatal psychiatry.
  • Child sexual abuse and maltreatment.

At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.

Team

Raquel Ibarz Lopez

Raquel Ibarz Lopez

Administration and Management
Psychiatry, Mental Health and Addictions
Read more
Sheila Garcia  Prado

Sheila Garcia Prado

Research assistant
Psychiatry, Mental Health and Addictions
Read more
Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more
Raquel Ibarz Lopez

Raquel Ibarz Lopez

Administration and Management
Psychiatry, Mental Health and Addictions
Read more
Sheila Garcia  Prado

Sheila Garcia Prado

Research assistant
Psychiatry, Mental Health and Addictions
Read more
Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more
Blog

News

A project led by the Vall d’Hebron Research Institute (VHIR) in collaboration with FIDMAG Germanes Hospitalàries Research Foundation describes structural and functional brain changes in adolescents with borderline personality disorder (BPD).

A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research